Double-Blind Randomized Cross-Over Trial of Dexamethasone and Prochlorperazine as Anti-Emetics for Cancer Chemotherapy
Authors:
- J.A. LeviJLJ.A. Levi
- R.L. WoodsRWR.L. Woods
- J. RussellJRJ. Russell
- J. MorganJMJ. Morgan
- Z. KerestesZKZ. Kerestes
- 1 January 1989
- journal article
- research article
- Published by S. Karger AG in Oncology
- Vol. 46 (2) , 105-108
Abstract
A double-blind randomized cross-over trial of dexamethasone and prochlorperazine as adjunctive anti-emetics with cancer chemotherapy was undertaken. The drugs were compared for cisplatin, doxorubicin and several other chemotherapy regimens. A total of 44 eligible patients were analysed. Assessment was made by questionnaire answered by the patient 24 h after the chemotherapy. The parameters compared were period of time for nausea and vomiting, number of vomiting episodes, degree of somnolence and insomnia and overall preference. In all cases there was no significant difference for either drug in its ability to suppress emetic effects. Neither drug gave adequate protection against cisplatin-containing regimens. We conclude that dexamethaxone alone is equivalent to the more standard dopamine antagonists.Keywords
This publication has 8 references indexed in Scilit:
- High-dose intravenous metoclopramide versus combination high-dose metoclopramide and intravenous dexamethasone in preventing cisplatin-induced nausea and emesis: a single-blind crossover comparison of antiemetic efficacy.Journal of Clinical Oncology, 1985
- Clinical characteristics associated with the development of anticipatory nausea and vomiting in cancer patients undergoing chemotherapy treatment.Journal of Clinical Oncology, 1984
- Methodologic issues in trials of antiemetics.Journal of Clinical Oncology, 1984
- Double-blind crossover study of the antiemetic efficacy of high-dose dexamethasone versus high-dose metoclopramide.Journal of Clinical Oncology, 1984
- Antiemetic efficacy of dexamethasone therapy in patients receiving cancer chemotherapyArchives of internal medicine (1960), 1983
- Methylprednisolone as an Antiemetic in Patients on Cis-Platinum Chemotherapy. Results of a Controlled Randomized StudyTumori Journal, 1983
- EFFECTIVE CONTROL OF CISPLATIN-INDUCED NAUSEA USING HIGH-DOSE STEROIDS AND DROPERIDOL1982
- Methylprednisolone as an antiemetic during cancer chemotherapy—a pilot studyGynecologic Oncology, 1980